How is the Male Hypogonadism Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the male hypogonadism market grown in recent years?
The market for male hypogonadism has seen substantial growth in recent years. Its size is forecasted to increase from $3.75 billion in 2024 to $3.99 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. Various factors including the aging population, public awareness and diagnosis, lifestyle factors, chronic illnesses, and a tendency to seek treatment have contributed to the growth observed in the historical period.
How is the male hypogonadism market size expected to evolve during the forecast period?
The market size for male hypogonadism is anticipated to significantly expand in the coming years, projecting a growth to $5.08 billion by 2029, with a compound annual growth rate (CAGR) of 6.2%. The projected growth within this period can be credited to factors such as increased awareness, the prevalence of lifestyle-associated conditions, breakthroughs in treatment methods, emphasis on male health, telemedicine, and accessibility of healthcare. The forecasted period will also witness major trends including a focus on mental and sexual health, the exploration of nutraceuticals and lifestyle modifications, market growth in developing economies, joint research efforts, and an emphasis on long-term safety and monitoring.
Get your male hypogonadism market report here!
https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report
Which key drivers are propelling the male hypogonadism market’s growth?
The escalation in infertility rates is predicted to spur the expansion of the male hypogonadism market in the future. Infertility is a disorder impacting the reproductive system of either gender and it is typified by an inability to conceive despite having regular unprotected sexual relations for a year or longer. Male hypogonadism, a potential cause of male infertility that could lead to a decrease in sperm production, is thereby implicated. Consequently, the growing incidence of male infertility is projected to fuel the male hypogonadism market’s growth. For instance, the UK’s Office for National Statistics reported in February 2024 that in 2022, the total fertility rate (TFR) escalated to 1.49 children per woman from 1.55 in 2021. Hence, the rising infertility rate is propelling the expansion of the male hypogonadism market.
What are the market segments in the male hypogonadism industry?
The male hypogonadism market covered in this report is segmented –
1) By Type: Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types
2) By Drug Delivery: Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries
3) By Therapy: Testosterone Therapy, Gonadotropin-Releasing Hormone Therapy
Subsegments:
1) By Klinefelter’s Syndrome: 47,XXY Syndrome, Other Variants
2) By Kallmann Syndrome: Isolated Kallmann Syndrome, Syndromic Kallmann Syndrome
3) By Pituitary Disorders: Hypopituitarism, Pituitary Tumors, Other Pituitary Disorders
4) By Other Types: Androgen Insensitivity Syndrome, Testicular Dysgenesis Syndrome, Genetic Mutations And Disorders
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9969&type=smp
Which leading companies are shaping the growth of the male hypogonadism market?
Major companies operating in the male hypogonadism market include Pfizer Inc., Bayer AG, Eli Lilly and Company Ltd., Endo International plc., Merck & Co. Inc., Ferring Pharmaceuticals, Finox Biotech AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Perrigo Company plc, IBSA Institut Biochimique SA, Sun Pharmaceutical Industries Limited, Glenmark Pharmaceuticals Limited, Antares Pharma Inc., Zydus Cadila LLC, Besins Healthcare Ltd., Clarus Therapeutics Holdings Inc., Foresee Pharmaceuticals Co. Ltd., Lipocine Inc., Myovant Sciences Ltd., Sandoz International GmbH, Shionogi & Co. Ltd., TherapeuticsMD Inc., Viking Therapeutics Inc.
What key trends are currently impacting the male hypogonadism market’s development?
Product innovation is emerging as a significant trend in the male hypogonadism marketplace. Companies in this sector are engineering new products to maintain their market standing. For example, Halozyme, an American biotech organization, unveiled Tlando in June 2022, an oral medication for testosterone replacement therapy for male hypogonadism. Tlando, a testosterone-containing prescription medicine, is the first orally administered testosterone treatment to receive FDA approval. The aim is to treat adult men who suffer from low to no testosterone levels due to various health conditions.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9969
Which geographic areas are influencing the growth of the male hypogonadism market?
North America was the largest region in the male hypogonadism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the male hypogonadism market report during the forecast period. The regions covered in the male hypogonadism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Biosimilar Therapeutic Peptides Global Market Report 2024
Gastrointestinal Bleeding Treatment Devices Global Market Report 2024
Medication Adherence Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/medication-adherence-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
